Genetic diagnostics is like comparing two photos taken with different cameras. If one camera slightly shifts the colors, the image will show "defects" that don't exist in reality. The same happens in DNA analysis: a patient's sample is compared to a reference, and if the reference was processed with reagents from a different batch or in a different lab, the comparison yields false signals — either extra mutations or missed real ones.
The authors propose catching such glitches by the "level of trust" between the data and the model. When the technique works as intended, the data fit the predictions well. When a reagent batch is spoiled or the instrument is miscalibrated, the data stop converging with the model — trust drops. The method looks for groups of samples with abnormally low trust and separates them from healthy ones. It's like finding photos with unnatural colors in an album: they stand out against the rest.
Testing on synthetic data showed that the method doesn't raise false alarms more often than expected. On real clinical panels (liquid biopsy, BRCA, and thalassemia) it found glitches caused by various reasons, from reagent changes to processing in different locations. And on mouse brain electrical activity recordings, the method worked just as well, even though the task is from a completely different field. This means the approach is universal: it catches any technical interference that spoils comparison with a reference.
Such a filter isn't just for show. In the clinic, a false mutation can send a person into unnecessary treatment, while a missed real one can leave them without help. The method allows sorting out spoiled tests before they reach the doctor's hands, thereby maintaining trust in genetic diagnostics.
The method was tested on mouse brain activity recordings, and it found technical glitches in the data, even though it was created for DNA analysis. It's like a counterfeit bill detector suddenly recognizing a forgery in a painting.